Related Experiment Video
Updated: May 16, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
GDF-15 prevents platelet integrin activation and thrombus formation
J Rossaint1, D Vestweber, A Zarbock
1Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Journal of Thrombosis and Haemostasis : JTH
|December 13, 2012
Summary
Growth-differentiation factor 15 (GDF-15) inhibits platelet integrin activation, decelerating thrombus formation and prolonging bleeding time. This discovery offers potential new treatments for bleeding disorders.
Area of Science:
- Hematology
- Molecular Biology
- Biochemistry
Background:
- Platelet integrins are crucial for primary hemostasis.
- Growth-differentiation factor 15 (GDF-15) inhibits leukocyte β(2)-integrin activation.
Purpose of the Study:
- To investigate the effect of GDF-15 on platelet integrin activation.
- To assess GDF-15's role in in vitro and in vivo thrombus formation.
Main Methods:
- In vitro and in vivo studies using GDF-15 deficient mice and recombinant GDF-15.
- Flow chamber assays, flow cytometry, and platelet aggregation studies.
- Investigated Rap1-dependent α(IIb)β(3) activation and PKA signaling.
Main Results:
- GDF-15 deficient mice exhibited accelerated thrombus formation and reduced survival.
- Recombinant GDF-15 decelerated thrombus formation and prolonged bleeding time.
- GDF-15 inhibited fibrinogen binding, β(1) and β(3) integrin activation, and platelet aggregation, specifically impacting Rap1-dependent α(IIb)β(3) activation via PKA.
Conclusions:
- GDF-15 specifically inhibits platelet integrin activation.
- Findings suggest GDF-15's potential therapeutic role in hemostatic conditions.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...